Publication date: Nov 04, 2019 Neurofilament light chain (NfL) is a promising marker of disease activity/treatment response in multiple sclerosis (MS), although its predictive value for long-term clinical outcomes remains ... Read more

Publication date: Jul 12, 2019 Glatiramer acetate (GA) is one of the first therapies approved for multiple sclerosis (MS). We prospectively included and monitored drug-nacEFve and pre-treated MS patients who ... Read more

Publication date: Jul 21, 2018 MS symptoms affect many functional domains. Knowing the specific impact of symptoms on health-related quality of life (HRQoL) is vital for successful disease and symptom ... Read more

Publication date: Aug 13, 2018 Multiple sclerosis (MS) is one of the most frequently observed neurological conditions in Switzerland, but data sources for country-wide epidemiological trend monitoring are lacking. Moreover, ... Read more